Genetic Chemistry Inc., a Bay Area subsidiary of Evolva SA, secured a contract worth up to $22.8 million from the U.S. Army Research Office to discover and develop novel compounds that act against the Gram-negative bacterium Burkholderia pseudomallei. (BioWorld International) Read More
